Jennifer Lynn Lessig, APRN General Practice Medicare: Medicare Enrolled Practice Location: 36 Willis Ave, Meriden, CT 06450 Phone: 203-558-3742 |
News Archive
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.
Researchers based at the Centers for Disease Control and Prevention (CDC) found that many primary care doctors would bring women back for cancer screening annually - while recommendations generally call for a three-year wait after normal tests. This translates to higher costs to women and the healthcare system, as well as a risk of unnecessary treatment for false-positive test results - with very little additional cancer-catching benefit say experts. Lead author Katherine Roland said, "There's really no advantage to annual screening compared to screening every two or three years."
Erika Holzbaur, PhD, a professor of Physiology in the Perelman School of Medicine at the University of Pennsylvania, has received the Javits Neuroscience Investigator Award from the National Institutes of Health.
So House Republicans have passed and sent to the Senate a budget that includes no funding for the Affordable Care Act, setting up a political showdown that could result in a government shutdown. We wish the GOP luck, since we support the policy if not the strategy. But however this charge into the fixed bayonets turns out, we hope the folks who planned it will take responsibility for what happens now (9/23).
› Verified 7 days ago